Home > Boards > US OTC > Medical - Healthcare > Nexteligent Holdings Inc. (NXGT)

Following are highlights from the Nexteligent Quarterly Report

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lvbic Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 06/16/20
160x600 placeholder
lvbic   Wednesday, 06/17/20 04:48:19 PM
Re: None
Post # of 22023 
Following are highlights from the Nexteligent Quarterly Report (March 31 2020)

• In order to facilitate and expedite the execution of the Company’s acquisition growth strategy, the Company’s CEO Paul Cristiano restructured and expanded the Board of Directors to include Majid Pishyar and Ehsan Pishyar of 32Group, providing direct access to 32Group’s extensive global business network, and new opportunities for cross- selling, international distribution, and growth capital.

• The Company announced the change in its name and symbol from Efftec International, Inc. (EFFI) to Nexteligent Holdings, Inc. (NXGT).

• Concurrent with the name change, Nextelignt announced its new organizational structure and launch of four strategic business units created to facilitate ongoing roll-ups of companies in revenue cycle management, telemedicine, chronic care management, and healthcare advisory services.

• Raymond Pomante joined the Company as President and Chief Operating Officer and as a member of the Board of Directors.

• In support of best practices in Corporate Governance, CEO Paul Cristiano transitioned his role as Chairman to Majid Pishyar, Chairman and founder of 32Group, a leading international conglomerate with businesses in healthcare, technology, energy, and construction.

• Nexteligent has actively explored acquisition targets in Revenue Cycle Management, Chronic Care Management, and Telemedicine and anticipates the finalization of Definitive Agreements and/or Letters of Intent for at least three target companies in 2020.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences